Cite
Cezar TC, Schweppe KW, Pletzer KR, et al. The cost-effective, but forgotten, medical endometriosis therapy: a prospective, quasi-randomized study on progestin therapy. Facts Views Vis Obgyn. 2018;10(4):181-190
Cezar, T. C., Schweppe, K. W., Pletzer, K. R., Becker, S., Krentel, H., Torres-De La Roche, L. A., & De Wilde, R. L. (2018). The cost-effective, but forgotten, medical endometriosis therapy: a prospective, quasi-randomized study on progestin therapy. Facts, views & vision in ObGyn, 10(4), 181-190.
Cezar, T C, et al. "The cost-effective, but forgotten, medical endometriosis therapy: a prospective, quasi-randomized study on progestin therapy." Facts, views & vision in ObGyn vol. 10,4 (2018): 181-190.
Cezar TC, Schweppe KW, Pletzer KR, Becker S, Krentel H, Torres-De La Roche LA, De Wilde RL. The cost-effective, but forgotten, medical endometriosis therapy: a prospective, quasi-randomized study on progestin therapy. Facts Views Vis Obgyn. 2018 Dec;10(4):181-190. PMID: 31367290; PMCID: PMC6658201.
Copy
Download .nbib